Prosecution Insights
Last updated: April 19, 2026

Intellexon GmbH

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17771793 HLA-H, HLA-J, HLA-L, HLA-V AND HLA-Y AS THERAPEUTIC AND DIAGNOSTIC TARGETS TURPIN, ZACHARY MARK 1682 Final Rejection Apr 25, 2022
17771662 HLA CLASS I MOLECULES IN IN VITRO FERTILIZATION AND FURTHER MEDICAL IMPLICATIONS BATES, KEENAN ALEXANDER 1631 Non-Final OA Apr 25, 2022
17625063 HLA-H IN MEDICINE AND DIAGNOSTICS WILSON, MICHAEL C 1638 Non-Final OA Jan 05, 2022

Managing Intellexon GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month